Food & Drug Administration
Latest From Food & Drug Administration
Which immuno-oncology candidates are poised to begin their first-in-human clinical trials? How many sponsors already have partners or collaborators? What oncology indications have been proposed? And where will these trials take place? Citeline's Rachel L. Meighan-Mantha has the data.
Mobile technology and wearables have been hailed by many as the golden future for operational efficiency and patient retention in clinical studies. Digital engagement expert Tim Davis discusses the pitfalls of selecting a one-size-fits-all strategy and waiting for trial processes and regulators to catch up.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.